Question 1

What specific criteria do I need to meet to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of MEK162 and paclitaxel compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

Question 3

What potential side effects should I be aware of with this combination therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer clinical trial (NCT01649336). Contact the study team or your healthcare provider for specific answers.

What this study is about